← Eichor
Study identifier: NCT06932848 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus

Condition: Oral Lichen Planus  ·  Sponsor: Chulalongkorn University

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized, double-blind clinical trial evaluates the therapeutic effects of curcumin in nanogels compared to 0.1% fluocinolone acetonide oral paste in the management of atrophic-erosive oral lichen planus (OLP). The study aims to determine whether curcumin nanogels, a natural treatment with enhanced bioavailability, are as effective and better tolerated than standard corticosteroid therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Tossapol Maneethorn, D.D.S.  ·  086-9253975  ·  comeblack_ubama@hotmail.com

Pirawish Limlawan, D.D.S., Ph.D.  ·  084-090-3309  ·  pirawish@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Dentistry, Chulalongkorn UniversityBangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06932848